Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma
Open Access
- 1 February 1998
- Vol. 82 (3) , 576-582
- https://doi.org/10.1002/(sici)1097-0142(19980201)82:3<576::aid-cncr21>3.3.co;2-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: